Stockscreener 앱 받기
5.09
4.52%
0.22
시간 외 거래:
5.19
0.10
+1.96%
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience CFO Frost buys $25,000 in HBIO stock - investing.com
Harvard Bioscience (NASDAQ: HBIO) CFO awarded 30,000 RSUs in equity grant - Stock Titan
Harvard Bioscience (HBIO) CFO adds 5,000 shares at $5.00 - Stock Titan
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Is Harvard Bioscience Inc stock a top performer YTD2026 Growth vs Value & Reliable Entry Point Alerts - baoquankhu1.vn
Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN
Debt to assets ratio of Harvard Bioscience, Inc. – MUN:HBI0 - tradingview.com
Trading Recap: Is Harvard Bioscience Inc forming a bullish divergenceWeekly Investment Summary & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
EBIT of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
HARVARD BIOSCIENCE (NASDAQ: HBIO) CEO receives 75,000-share stock grant - Stock Titan
William Snider Secures Board Seat at Harvard Bioscience with 15.97% Stake - TradingView
BroadOak reports 16% Harvard Bioscience (HBIO) stake tied to loans and warrants - Stock Titan
Harvard Bioscience stock faces scrutiny amid Q4 earnings anticipation and life sciences sector volat - ad-hoc-news.de
Taxes of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience Outlines Post-Refi Strategy, Organoid Growth Focus - National Today
Total equity of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LS:A423J5 - TradingView
Free cash flow per share of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Cash per share of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Harvard Bioscience, Inc. Cash Flow – GETTEX:HBI0 - TradingView
Net income of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Price to earnings ratio of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Net debt of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Return on assets % of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LSX:A423J5 - TradingView
Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - gurufocus.com
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares - MarketBeat
Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan
Harvard Bioscience director Snider buys $103,603 in HBIO stock By Investing.com - Investing.com Australia
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares - MarketBeat
Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com
Harvard Bioscience (HBIO) director buys 21,000 shares on open market - Stock Titan
Harvard Bioscience CEO Duke buys $25k in shares By Investing.com - Investing.com Australia
Layoff Watch: What are analysts price targets for Harvard Bioscience IncTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Insider Buying: John Duke Acquires 5,000 Shares of Harvard Biosc - gurufocus.com
Harvard Bioscience CEO Duke buys $25k in shares - Investing.com
Harvard Bioscience (HBIO) CEO adds shares and holds major RSU awards - Stock Titan
Harvard Bioscience at KeyBanc Forum: Strategic Growth and Market Focus By Investing.com - Investing.com Canada
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning - TipRanks
Market Trends: Whats next for Harvard Bioscience Inc stockRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Harvard Bioscience provides investor presentation; FY25 results, FY26 guidance and strategic actions - TradingView
Harvard Bioscience (NASDAQ: HBIO) posts FY25 metrics and guides modest 2026 growth - Stock Titan
HBIO: Benchmark Raises Price Target to $6.00, Maintains Speculat - GuruFocus
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split - Investing.com Australia
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split By Investing.com - Investing.com India
How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations - Yahoo Finance
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com Nigeria
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - gurufocus.com
Benchmark cuts Harvard Bioscience stock price target on NIH concerns By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
1.45%
0.76%
자본화:
|
볼륨(24시간):